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media were harvested. TGF- secretion in response to stress was determined
by ELISA.
Results: No difference was noted in the number of TGF-RI-positive
and TGF-RII-positive cells between a-fbs and nn-fbs; however, TGF-RII
density was reduced 40% as determined by MFI in a-fbs compared with
nn-fbs (151 25 vs 51 27, n 6; P .03). In healthy commercial nn-fbs
subjected to constant mechanical stress for 24 hours, there was no change in
TGF- secretion compared with the static (control) nn-fbs. However, there
was a fourfold increase in TGF- secretion (284  133 vs 1076  238
pg/mL, n  4; P  0.03) in a-fbs exposed to mechanical stress compared
with their control.
Conclusions: Previous studies investigating venous ulcer fibroblasts
have shown alterations of TGF-  and their receptors. This study reveals that
these alterations may occur as part of the normal aging process as demon-
strated by baseline differences seen between nn-fbs and a-fbs. Furthermore,
a-fbs should be considered for use as controls because they possess normal
age-specific characteristics that maymore closely reflect venous disease in the
adult population.
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Background: Post-thrombotic syndrome (PTS) is characterized by a
fibrotic vein injury after deep vein thrombosis (DVT), resulting in a less
compliant vein wall. We sought to quantify the change in vein wall thickness
and to determine if vein wall damage, defined as wall thickening, is worsened
in patients when DVT fails to resolve by 6 months, and also whether there
were differences in blood or plasma levels of proteins associated with tissue
remodeling.
Methods: Patients presenting with suspected lower extremity DVT
were evaluated. Ultrasound imaging of the lower extremity venous system
was performed, and blood was collected. Patients with DVT received repeat
evaluation with blood draw and ultrasound imaging at 6 months. DVT
resolution was assessed using ultrasound examination. The thickness of the
vein wall was quantified by ultrasound imaging in each segment affected by
thrombus, and a contralateral, unaffected vein wall served as a control.
Messenger RNA was extracted from whole blood using the PAXgene
system, and serum proteins were analyzed using enzyme-linked immunosor-
bent assay (ELISA). Analysis of variance or t tests were used. P  .05 was
significant.
Results: Thirty patients (10 with DVT resolution at 6 months, 10 with
persistent thrombus, and 10 healthy controls) were compared. Resolving
and nonresolving DVT were both associated with 1.5- to 1.8-fold increased
vein wall thickness at 6 months (n  10-12; P  .008) compared with
nonaffected vein wall segments. However, the thickness of the affected
segments was 1.4-fold greater in patients who had total resolution of the
DVT by 6 months than in patients who had persistent chronic thrombus 6
months after presentation (n  10-12; P  .01,). There was a four- to
fivefold increased level of MMP-9 in all thrombosed groups compared with
controls (n  5; P  .05). Toll-like receptor-9 (TLR-9) expression was
threefold less than in controls (n  5; P  .05). There were no statistically
significant differences in the levels of associated factors such as D-dimer,
P-selectin, or inflammatory and remodeling markers such as SLC or matrix
metalloproteinase (MMP)-2 by ELISA. There were no significant differ-
ences in the gene expression of C-reactive protein, MMP-2, MMP-9, or
TLR-4.
Conclusions: This preliminary study suggests ongoing vein wall re-
modeling after DVT. At 6 months, the vein wall is markedly thickened, but
this change is independent of thrombus resolution and is associated with
elevatedMMP-9 but not other inflammatory markers. This suggests that the
vein wall damage is initiated early after thrombus formation and persists even
in the presence of total resolution.
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Background: In a difficult economic context, the burden of chronic
diseases is becoming a greater concern for public health authorities. Health
care professionals and institutions need an evaluation tool to assess objec-
tively the burden of chronic venous disorders and its consequences. This
study is a very preliminary approach.
Methods: A questionnaire was developed according to a strict meth-
odologic process to guarantee its credibility and reliability. A literature
review and face-to-face interviews enabled the identification of 66 items
linked to the pathology. Items were reduced to 36 after evaluation and
suppression of redundant, nonspecific, and nonsensitive items.
Results: Exploratory evaluations have shown that the concept of
burden could be structured around six aspects: pain, daily life, family and
personal relationships, work, psychologic effect, and treatment by a general
practitioner. For a complete evaluation of the burden, evaluation of these six
aspects was complemented with three visual analog scales (VAS): psycholog-
ical, physical, and living with the disease. The Assessment of Burden in
Chronic–Venous (ABC-V) Disorders questionnaire was administered to
individuals consulting spontaneously for CVD with a phlebologist, who
confirmed the CVD. Eight centers throughout France recruited 328 indi-
viduals: 82.7% were women (average age, 54.6  13 years), 59% had a
professional activity, and 32% were overweight or obese according to the
body mass index. The correlations between the ABC-V score and the
Specific Quality of Life and Outcome Response – Venous (SQOR-V and
Center for Epidemiologic Studies Depression Scale (CES-D)scores (recog-
nized and validated questionnaires) were sought. The ABC-V score is highly
positively correlated to SQOR-V and CES-D scores. The three aspects with
the greatest impact on the burden were the Pain, Physical, and Living with
the Disease VAS. The two aspects with the lowest impact on the burden are
Treatment by GP and Family Life (Table).
Conclusions: Chronic pathologies such as venous disease remain
frequent and crippling diseases that are difficult to assess with only clinical
elements or QOL instruments because the effect can be multidimensional.
Several existing questionnaires attempt to evaluate one or another of these
aspects. The ABC-V takes them all into consideration to express the global
nature of the handicap and burden of chronic diseases.
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Background: The lymphatic system possesses numerous active pumps
to propel lymph to the central lymphatic systems. Decreased pumping
activity may be associated with lymphedema. However, there are no nonin-
vasive methods to measure lymphatic pump force in clinical practice. The
aim of this study was to introduce a new method to measure lymphatic
pumping and compared the activity between healthy and lymphedematous
legs using indocyanine green (ICG) fluorescence lymphography.
Methods: ICG fluorescence lymphography was performed by subcu-
taneously injecting 0.3mL of ICG (10% in normal saline) into the dorsum of
the foot. Fluorescence images were obtained with an infrared-light camera
system in a supine position. Sphygmomanometer cuffs were wrapped around
the lower legs and connected to a standard mercury sphygmomanometer.
The cuffs were inflated to 60 mm Hg, then, gradually deflated to lower the
pressure by 10-mm Hg steps until the fluorescence dye exceeded the upper
border of the cuff, when the lymphatic contraction overcame the cuff
pressure. The value of the cuff pressure was taken as lymph pumping pressure
(Ppump; Fig 1). In nine volunteers without swollen legs (18 legs), we
compared the Ppump obtained with ICG fluorescence lymphography with
that obtained from dynamic lymphoscintigraphy. With dynamic lympho-
scintigraphy, Ppump was measured from the time-activity curves using the
same sphygmomanometer cuff technique (Fig 2). With ICG fluorescence
lymphography, we compared Ppump between 27 healthy volunteers (54
legs) and 22 lymphedema patients (26 swollen legs).
BVD, Burden of vascular disease; SD, standard deviation; VAS, visual analog
scale.
Fig. Assessment of Burden in Chronic-Venous results
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